1 terminated, 1 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
Follow Impaired Glucose Tolerance: new trials by email Literature Review of Impaired Glucose Tolerance trials Research Report on Impaired Glucose Tolerance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GLU-xx Formulations in Individuals With Impaired Glucose Tolerance GLU-01, GLU-02, GLU-03 - Impaired Glucose Tolerance | Phase 1 | Terminated | Afexa Life Sciences Inc | 17 | 2011-02-01 | 2012-01-31 |
| Investigation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LIM-0705 in Male Subjects With Impaired Glucose Tolerance LIM-0705, Placebo - Impaired Glucose Tolerance | Phase 1 | Withdrawn | Limerick BioPharma | 30 | 2010-03-01 | 2010-06-08 |
Glucose Metabolism Disorders (2) · Hyperglycemia (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2)
Afexa Life Sciences Inc (1) · Limerick BioPharma (1)
United States (1)
Albert Frauman, MD (1) · Jay Udani, MD (1)